Absorption and emission properties

Spectrometric titrations
The titrations were performed in BPE buffer (pH = 7.0; 2a,b: with 5% v/v DMSO) with ct DNA and in K-phosphate buffer (pH = 7.0; 2a,b: 5% v/v DMSO) with quadruplex DNA. To avoid the dilution of the solution of the ligand during titration, the titrant solution contained the same ligand concentration as the analyte solution. In fluorimetric titrations the excitation wavelength usually corresponded to an isosbestic point or to an absorption wavelength that does not change signifcantly during titration, as determined by photometric titrations. After recording the absorption or fluorescence spectrum of the solution of the ligand, the respective DNA was added stepwise until no more significant changes of the absorption or fluorescence intensity could be observed. The equilibration time after each addition was 3 min.
From the fluorimetric or photometric titrations, the binding constants were calculated by fitting the experimental data to the theoretical model (eq. S1 and eq. S2). 1
(eq. S2) F 0 = the background fluorescence(absorption intensity of ligand in the absence of DNA F max = fluorescence intensity/absorption upon saturation n = putative number of ligand molecules binding to a given DNA strand
The parameters Q and A were evaluated with the Levenberg-Marquardt non-linear curve fitting algorithm as implemented in the Origin 8.5 software.
In the case of ligand 2c, the titration data with ct DNA were presented as Scatchard plots, i.e. r / c vs. r values, and numerically fitted to the neighbor exclusion model of McGhee and von Hippel (eq. S3). 2,3 The numerical fitting was performed with the Levenberg-Marquardt non-linear curve fitting algorithm as implemented in the Origin 8.5 software.
A f is the absorbance/emission of the free ligand at a given wavelength, A b is the absorbance/emission of the bound ligand, and A is the absorbance/emission at a given ligand-to-DNA ratio. Figure 2 , A2) and fit of the experimental data to the theoretical model (eq. S1). B: Scatchard plot of r / c versus r from spectrophotometric titration of ct DNA to 2c in BPE buffer (cf. Figure 2 , A3) and fit of the experimental data to the theoretical model (eq. S3).
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Thermal DNA melting analysis (FRET melting)
Separate stock solutions of the dye-labeled oligonucleotides F21T (5'-fluorescein-dGGGTTA-GGGTTAGGGTTAGGG-tetramethylrhodamine) or Fa2T (5'-fluorescein-dACAGGGGTGTG-GGACAGGGGTGTGGGG-tetramethylrhodamine) (50 µM) and the ligands (20 µM) were prepared, respectively, in cacodylate buffer (10 mM sodium cacodylate, 100 mM LiCl, 90 mM LiCl and 10 mM KCl or 90 mM NaCl and 10mM LiCl, pH 7.2). The ligand solution was diluted to concentrations of 0.2, 0.5, and 1.0 µM, respectively, and the samples were placed in an ultrasonic bath for 10 min. For each experiment, DNA solution was added to the analyte solution to obtain a DNA concentration of 0.2 µM. To record the melting curves, the following experimental settings were used:
Excitation wavelength 470 nm
Emission wavelength 515 nm Excitation slit 5 nm Emission slit 5 nm
The following heating-cooling sequence was used:
1) heating from 20 °C to 90 °C at 2.5 °C min -1 ;
2) holding the max. temperature for 5 min;
3) cooling to 10 °C at 1.0 °C min -1 ; 4) heating from 10 °C to 99 °C at 0.2 °C min -1 ; the fluorescence was detected during the latter ramp.
The normalized fluorescence intensities were plotted versus temperature. The melting temperature was determined as the maximum of the first derivative of the melting curve approximated by the Gaussian function. The shift of the melting temperature was calculated as ΔT m = T m (DNA-Ligand) -T m (DNA). The arrows indicate the development of the melting curves with increasing LDR (0, 1.3, 2.5, and 5.0 molar equivalents).
CD-spectroscopic analysis
Solutions of DNA, the ligand and BPE buffer were measured after an equilibration time of 30 min. The CD spectra were determined with the following experimental settings:
Wavelength range 220-550 nm p o rt w a s c re a te d b y A C D /N M R P ro c e s s o r A c a d e m ic E d itio n . F o r m o re in fo rm a tio n g o to w w w .a c d la b s .c o m /n Figure S7 . 1 H-NMR spectrum (600 MHz) of 2b in DMSO-d 6 . Figure S8 . 13 C-NMR spectrum (150 MHz) of 2b in DMSO-d 6 . Figure S9 . 1 H-NMR spectrum (600 MHz) of 2c in DMSO-d 6 .
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